Johnson & Johnson has to pay $ 4.7 billion worth of damages to cancer patients!
The US court has ordered Johnson & Johnson (J & J) hygiene and drug manufacturer to pay $ 4.7 billion in damages to 22 women who were suffering from ovarian cancer due to the use of his talc products
A jury in the US state of Missouri ruled that the company must pay an initial fee of $ 550 million, adding to that, and a $ 4.1 billion worth of damages, the BBC reported on Friday. During the six weeks of the trial, women and their families testified that they were suffering from ovarian cancer after decades of using baby powder and other talc products. Their lawyers claimed that in the company since the 1970s they knew their talk was polluted by asbestos but did not warn consumers about the risks.
In J & J they rebelled these claims, emphasizing that their products do not contain asbestos and do not cause cancer. Talk is a mineral and sometimes in the ground can be found near asbestos, BBC reports. The pharmaceutical diva emphasized that several studies showed that the talk was safe, emphasizing that the judgment was a product "basically an unjust procedure". They expressed disappointment with the verdict and announced the appeal.
The US Food and Drug Administration (FDA) has commissioned research into various talc samples, including J & J. The research was conducted from 2009 to 2010 and the asbestos was not found in any one cause, BBC reports. The prosecutor told the Missouri court that the FDA and J & J used the wrong test method. The total amount of damages of 4.7 billion dollars is the highest in the procedures that J & J faces with claims that its products have caused cancer.
Last year, a jury in the US state of California ordered a $ 417 million damages to a woman who claimed to have had ovarian cancer after using J & J's products, including baby powder. Subsequently, the judge annulled that judgment. Currently, nine thousand court proceedings against his famous baby powder are being conducted against the pharmaceutical giant, BBC reports.
- 15 Jul, 2018
- 1927 views
- No comments